SOD1 and early-onset autosomal dominant Alzheimer disease: Interestingly, the activities of SOD and GPx were upgraded by treatment with 2-BFI after SCI, which was consistent with the effect of 2-BFI in Alzheimer’s disease (Tian et al., 2017).